Sibutramine Hydrochloride

CHEMBL3989830 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
316.3 g/mol
LogP
Phase
4

Sibutramine hydrochloride is the hydrochloride salt form of sibutramine, a serotonin-norepinephrine reuptake inhibitor formerly used for obesity management that was withdrawn due to cardiovascular safety concerns. See sibutramine for complete pharmacological details.

Moleküler Ağırlık

316,3000 g/mol

TPSA

3,20 Ų

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl.O

InChI

InChI=1S/C17H26ClN.ClH.H2O/c1-13(2)12-16(19(3)4)17(10-5-11-17)14-6-8-15(18)9-7-14;;/h6-9,13,16H,5,10-12H2,1-4H3;1H;1H2

Molecular Formula

C17H27Cl2N

HBD / HBA

1 / 1

Döndürülebilir Bağlar

5

Ağır Atomlar

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Sibutramine hydrochloride is the hydrochloride salt form of sibutramine, a serotonin-norepinephrine reuptake inhibitor formerly used for obesity management that was withdrawn due to cardiovascular safety concerns. See sibutramine for complete pharmacological details.

Yes, Sibutramine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3989830. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 64764. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.